PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Shenzhen Third People\'s Hospital, Shenzhen, Guangdong, China.\', \'Department of Infectious Diseases, Shanghai Public Health Clinical Center, Shanghai, China.\', \'Clinical Laboratory, The Fifth People\'s Hospital of Wuxi, Jiangnan University, Wuxi, Jiangnan, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.5582/bst.2021.01361
?:doi
?:hasPublicationType
?:journal
  • Bioscience trends
is ?:pmid of
?:pmid
?:pmid
  • 34456212
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.591
?:rankingScore_hIndex
  • 23
is ?:relation_isRelatedTo_publication of
?:title
  • Considerations and guidance to control the rebound in COVID-19 cases.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all